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Abstract 
 
Biopolymers have become important drug delivery systems for therapeutic molecules by 
enhancing their accessibility and efficacy intracellularly. However, the transport of these 
drugs across the cell membrane and their release into the cytosol remain a challenge. The 
trafficking of poly (L-lysine iso-phthalamide) grafted with phenylalanine (PP-50) was 
investigated using an osteosarcoma cell line (SAOS-2). Colocalisation of this amphipathic 
biopolymer with endocytosis tracers, such as transferrin and lactosylceramide, suggested 
that PP-50 is partially internalised by both clathrin and caveolin-mediated endocytosis. 
Macropinocytosis was also investigated, but a smaller correlation was found between this 
mechanism and PP-50 transport. A significant decrease in polymer-mediated calcein uptake 
was found when cells were pre-incubated with endocytosis inhibitors, suggesting also the 
use of a combination of mechanisms for cell internalisation. In addition, PP-50 colocalisation 
with endosome and lysosome pathway markers showed that the polymer was able to 
escape the endolysosomal compartment before maturation. This is a critical characteristic of 
a biopolymer towards use as drug delivery systems and biomedical applications.  
 
Key words 
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1. Introduction 
 
In the past years, biopolymers have become an attractive choice as drug delivery systems. 
Their role in this field has been long recognised, with controlled release of therapeutic drugs 
over long periods, easy conjugation for active targeting, cyclic dosage, and adjustable 
release of both hydrophilic and hydrophobic molecules [1,2]. 
 
Biopolymers can successfully transport a variety of molecules across mammalian cell 
membranes, such as cancer therapy candidates and proteins [3,4]. The transport of these 
polymers along different therapeutics to a particular site within cells has shown a drastic 
improvement in the accessibility and efficacy of drugs [5]. However, most of the transport of 
these carriers through the cell membrane ends trapped within the endolysosomal pathway, 
with both the carrier and delivery molecule unable to reach their target [6,7]. This issue has 
hindered the use of several biomolecules and has been recognised as a critical barrier to 
further advancement in the field [8,9]. 
 
Endocytosis is a complex internalisation process involved in the uptake of different 
molecules. Depending on the properties of the internalised molecules, this process can take 
place using different mechanisms, such as phagocytosis and pinocytosis. Phagocytosis is 
the cell engulfment of solid particles, a key mechanism of innate immunity, while pinocytosis 
is a receptor-mediated uptake of smaller particles present in all cell types [10,11]. 
Pinocytosis can be divided in three separate processes: macropinocytosis (MPC), clathrin-
dependent (CDE), or clathrin-independent endocytosis (CIE). The caveolin-mediated 
pathway (CavME) is a subdivision of CIE.  
 
For efficient intracellular delivery of therapeutics, delivery systems need to facilitate their 
release into the cytoplasm by the disruption of endosomal membranes under moderate 
acidic conditions (pH 5.0–6.8) [12,13]. One effective method to achieve this disruption 
involves the use of anionic amphipathic biodegradable pH-responsive polymers. These 
molecules undergo a conformational change from extended charged chains to aggregated 
hydrophobic structures as the environmental pH drops below their pKa, thus interacting with 
the hydrophobic interior of phospholipid bilayers. In low pH environments, the carboxylate 
groups become protonated and hydrophobic interactions within the polymer backbone 
generate a transition to a compacted lipid membrane disruptive state [14]. This transition has 
been manipulated by the grafting of L-phenylalanine on the pendant carboxylic acid, 
resulting in a maximal lytic activity at pH 6.5, a characteristic pH range of early endosomes 
[12].  
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PP-50, an amphipathic polymer, has shown recently to be able to transport hydrophilic 
molecules into cells and to be biocompatible [15,16]. Despite its successful use in 
cryopreservation, the trafficking of PP-50 through cell membranes has not been previously 
investigated in depth. In this study, the fate of PP-50 when entering the endocytic pathway 
was evaluated in osteosarcoma cells, a model for adherent cells, to provide key information 
regarding this amphipathic biopolymer towards use in cryopreservation and other biomedical 
applications. 
 
2. Materials and methods 
 
2.1. Materials 
 
The SAOS-2 cells were obtained from the European Collection of Cell Cultures. Dulbecco’s 
modified Eagle’s medium (DMEM), foetal bovine serum (FBS), L-glutamine, penicillin, and 
streptomycin were purchased from Invitrogen (UK). Dimethyl sulfoxide (Me2SO) and sodium 
hydroxide (NaOH) were purchased from ThermoFisher (UK). Phosphate-Buffered Saline 
(PBS), trypsin–EDTA, Alexa Fluor 647 cadaverin, transferrin-AF488, lactosylceramide 
(lacCer)-BODIPY, fluorescein isothiocyanate–dextran, CellLight Early Endosomes-GFP, 
CellLight Late Endosomes-GFP, CellLight Lysosomes-GFP, and Lysotracker® Deep Red 
were purchased from Life Technologies™ (UK). The CellTiter 96® AQueous One Solution 
Cell Proliferation Assay (MTS) was obtained from Promega (UK). Bafilomycin A1 (BafA1), 
methyl-beta-cyclodextrin (mβcd), nystatin, sucrose, rottlerin, N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC), N-hydroxysuccinimide (sulfo-NHS), calcein, 
propidium iodide (PI) and Hoechst H33342 were obtained from Sigma-Aldrich (UK). Visking 
tubing was purchased from Medicell Membranes Ltd. (UK). All chemicals and biochemicals 
used were of analytical grade.  
 
2.2. Polymer synthesis and characterisation 
 
2.2.1. PP-50 
 
The synthesis and characterisation of PP-50 were as previously described by Eccleston and 
Chen [17,18]. Briefly, PP-50 synthesis involved two sections: synthesis of the polymer 
backbone, and the amino acid grafting. The backbone consisting of poly (L-lysine iso-
phthalamide) (PLP) was synthesised by a polycondensation reaction between L-lysine 
methyl ester dihydrochloride and iso-phthaloyl chloride to form poly (L-lysine methyl ester 
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iso-phthalamide). In order to remove the methyl group, the solution was dissolved in Me2SO 
(0.5 M) and then mixed with 5 % (w/v) NaOH. The hydrolysed product precipitated and was 
collected by vacuum filtration and dissolved in deionised water. Dialysis purification and 
lyophilisation produced PP-50 in powder. The grafting of L-phenylalanine to the backbone 
was achieved by the use of standard DCC/DMAP mediated coupling techniques. PP-50 is 
used in cell culture as a solution at a concentration of 250 µg/ml. 
 
2.2.2. PP-50/AF647 
 
The conjugation of the dye Alexa Fluor 647 cadaverine (AF647) to PP-50 was achieved by 
standard EDC/sulfo-NHS amide reaction [19]. Briefly, PP-50 and AF647 were conjugated 
using the coupling reactants N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride 
(EDC) and N-hydroxysuccinimide (sulfo-NHS). PP-50 was dissolved in a mixture of DMSO 
and water. Subsequently, EDC and sulfo-NHS were dissolved in water. This mixture was 
added to the PP-50 solution and the reaction was then incubated at room temperature for 1 
hour. Next, AF647 cadaverine was dissolved in 1 M Na2CO3 and added to the activated PP-
50/EDC/sulfo-NHS mixture to react at room temperature overnight in the dark. After this 
incubation, 5 % DMSO in D-PBS was added to the mixture to dilute the solution and dissolve 
any precipitate. The final solution was dialysed for a week (MWCO 3,500 Da) and the water 
was changed every other day. Subsequently, the solution was transferred to a 50 ml tube 
and 1 M HCl was added to precipitate the labelled polymer. The solution was then 
centrifuged at 1,500 G for 3 min to recover a blue solid. This precipitate was dissolved in 1 M 
NaOH and D-PBS and the solution was then dialysed against water for 3 hours and 
lyophilised using a Fisher Scientific Heto LyoLab3000 (UK) to yield a blue solid powder. 
 
PP-50/AF647 was analysed by using attenuated total reflectance Fourier transform infrared 
(ATR-FTIR) spectroscopy to determine whether PP-50 were successfully conjugated with 
Alexa Fluor 647 cadaverine. Spectra were collected using a Thermo Nicolet Nexus 870 
spectrometer (Waltham, MA, USA) as the average of 32 scans with a wavenumber 
resolution of 4 cm-1 in the 600-4000 cm-1 range. 
 
2.3. Cell culture 
 
SAOS-2 osteosarcoma cells were cultured in DMEM with FBS (10 % v/v), L-glutamine (2 
mM), penicillin (100 IU/ml), and streptomycin (100 µg/ml) in 75 cm2 flasks supplied by 
Corning (UK). Cells were incubated in a 37 °C incubator with 5 % of CO2. At 70 % 
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confluence, cells were washed twice with PBS, then subcultured with trypsin (0.05 % w/v) 
and EDTA (0.02 % w/v) and subsequently replated for further expansion or experiments.  
 
2.4. Colocalisation of PP-50 with endocytosis tracers 
 
Cells were seeded on 1.8 cm2 chambered cell culture cover glasses (Nunc, UK) at a density 
of 3 x 104 cells/well. Cells were grown for 24-48 hours and then incubated for 2 hours with 
100 µg/ml transferrin-AF488, 2 µM lacCer-BODIPY or 1 mg/ml fluorescein isothiocyanate–
dextran (150 kDa) in the presence of 250 µg/ml PP-50/AF647. Subsequently, cells were 
incubated for 15 minutes with 5 µg/ml Hoechst 33342; this permeable dye is used to 
evaluate nuclear morphology as it emits fluorescence when bound to DNA. Cells were 
washed twice with PBS and extracellular labelled molecules were quenched using 0.4 % 
trypan blue [20]. Cells were washed again with PBS and left in growth media. Cells were 
analysed using a TCS SP5 inverted laser scanning microscope (Leica, Germany). An argon 
laser was used to visualise transferrin-AF488, lacCer-BODIPY, and fluorescein 
isothiocyanate–dextran (emission at 488 nm and an emission filter set at 505-555 nm). To 
visualise PP-50/AF647, a helium neon laser was used (emission at 633 nm and emission 
filter set at 650-700 nm). H33342 stained nuclei were excited using a diode laser emitting at 
405 nm. Images were taken sequentially.  
 
2.5. Image analysis  
 
Fluorescent images of cells incubated with labelled transferrin, lacCer or dextran in the 
presence of labelled PP-50 were acquired using the appropriate wavelengths for each 
molecule, as explained above. Images were then merged and converted to 8 bit RGB 
images using ImageJ software. Analysis with the JACoP plugin provided Manders' overlap 
coefficient.  
 
2.6. PP-50 mediated transport of endocytosis tracers 
 
Cells were passaged into 24-well plates at a density of 5 x 104 cells/well and grown for 24-48 
hours. Cells were then washed with PBS and incubated with 100 µg/ml transferrin-AF488, 2 
µM lacCer-BODIPY or 1 mg/ml fluorescein isothiocyanate–dextran, in the presence and 
absence of 250 µg/ml PP-50 for 2 hours. The uptake of endocytosis tracers was assessed 
using a FACScan flow cytometer (Becton Dickinson, USA). Data were acquired using 
Cellquest software and analysed using the Beckman Coulter Summit software.  
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2.7. Toxicity screening of endocytosis inhibitors 
 
Cells were passaged into 96-well plates at a density of 5 x 103 cells/well and grown for 24 
hours. Cells were then washed with PBS and incubated with various concentrations of 
mβcd, nystatin, sucrose, and rottlerin for 2 hours. The toxicity was evaluated by quantifying 
metabolic activity using the CellTiter 96® AQueous One Solution Cell Proliferation Assay 
(MTS) according to the manufacturer’s instructions. Absorbance was measured at 490 nm 
using a 96-well plate reader (BMG Labtech, UK) and corrected by subtraction of background 
absorbance. 
 
2.8. Pre-treatment with endocytosis inhibitors 
 
For inhibition studies, 5 x 104 cells/well were seeded in 24-well plates and grown for 24-48 
hours. Cells were subsequently pre-incubated for 1 hour with CavME inhibitors 5 mM mβcd 
and 250 µg/ml nystatin, CDE endocytosis inhibitor 300 mM sucrose, and MPC inhibitor 2.5 
µM rottlerin. Calcein, a non-permeable hydrophilic dye which accounts for the activity of 
cytoplasmic esterases, was used to stain cells capable of incorporating it into their cytoplasm 
[18]. Cells were then incubated for 1 hour at 37 °C with 2 mM calcein and 250 µg/ml PP-50. 
A different treatment consisted of cells incubated for 1 hour with 2 mM calcein and 250 µg/ml 
PP-50 at 4 °C. For calcein uptake quantification, cell were analysed using a FACScan flow 
cytometer (Becton Dickinson, USA). Data were acquired using Cellquest software and 
analysed using the Beckman Coulter Summit software. 
 
2.9. Colocalisation of PP-50 with endosomal pathway markers 
 
Cells were seeded on 1.8 cm2 chambered cell culture cover glasses (Nunc, UK) at a density 
of 3 x 104 cells/well and grown for 24-48 hours. Cells were then transduced with CellLight 
reagents according to the manufacturer’s instructions. Briefly, cells were incubated for 16 
hours with 30 µl of CellLight solution with baculovirus containing either early endosomes 
Rab5a-GFP, late endosomes Rab7a-GFP or lysosomes Lamp-1-GFP. After this period, cells 
were washed twice with PBS, incubated with 250 µg/ml PP-50/AF647 for 2 and 24 hours 
and finally incubated for 15 minutes with 5 µg/ml H33342. Cells were washed twice with PBS 
and extracellular labelled molecules were quenched using 0.4 % trypan blue. Cells were 
washed again with PBS and left in growth media. Cells were analysed using a TCS SP5 
inverted laser scanning microscope (Leica, Germany). An argon laser was used to visualise 
the GFP labelled early endosomes, late endosomes and lysosomes (excitation at 488 nm 
and emission filter set at 505-555 nm). To visualise PP-50/AF647, a helium neon laser was 
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used (excitation at 633 nm and emission filter set at 650-700 nm). H33342 stained nuclei 
were excited using a diode laser emitting at 405 nm, with an emission filter set between 425 
nm and 475 nm. 
 
2.10. Statistical analysis 
 
All measurements were carried out by triplicate in three different replicates. Flow cytometry 
results were analysed using a one-way ANOVA followed by a Tukey’s test for multiple 
comparisons. The tests were analysed using GraphPad Prism (GraphPad Software, US). 
The difference was considered statistically significant when p < 0.05. 
 
3. Results 
 
3.1 Colocalisation of PP-50 with endocytosis tracers 
 
The colocalisation of PP-50 with endocytosis tracers was analysed by confocal microscopy. 
Cells were incubated with labelled PP-50 (red fluorescence) and either with labelled 
transferrin, lacCer, or dextran (green fluorescence) (Fig. 1). The colocalisation of these 
endocytosis tracers with PP-50 is shown as orange. As seen in the figure, osteosarcoma 
cells readily incorporated PP-50/AF647 intracellularly. The labelled polymer appeared in the 
cytoplasm, located mainly in the perinuclear space. Endocytosis tracers were also 
transported across the cell membrane, as confirmed by intracellular staining of cells. A 
higher colocalisation was observed with transferrin and lacCer, with both tracers 
accumulated in sites close to the cell nucleus. On the other hand, dextran intracellular signal 
was lower when compared to transferrin or lacCer. Cells also displayed normal nuclei 
features, shown by the staining with Hoechst H33342. 
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Figure 1: PP-50/AF647 colocalisation analysis with endocytosis tracers on SAOS-2 by confocal 
microscopy. Cells were incubated with transferrin-488, lacCer-BODIPY or dextran-fluorescein 
isothiocyanate (green fluorescence) and 250 µg/ml PP-50/AF647 for 2 hrs (red fluorescence). 
Subsequently cells were stained with 5 µg/ml Hoechst H33342 (blue fluorescence) for 15 min. Data 
are representative of a minimum of three separate experiments. 
 
3.2 Image analysis of PP-50 colocalisation with endocytosis tracers 
 
The analysis of the colocalisation PP-50 with endocytosis tracers was assessed by using 
ImageJ software and at least 5 independent images for each marker. The Manders’ overlap 
coefficient was derived with the JaCoP ImageJ tool. The coefficient was 0.548 ± 0.048 for 
CDE, 0.471 ± 0.067 for CavME, and 0.336 ± 0.078 for MPC. 
 
3.3. PP-50 mediated transport of endocytosis tracers 
 
To assess whether PP-50 was directly involved in the transport of endocytosis tracers, cells 
were incubated with transferrin, lacCer, and dextran in the presence and absence of PP-50. 
The uptake of these tracers was investigated using flow cytometry (Fig. 2). As seen in Fig. 2, 
a significant uptake increase of transferrin (10 ± 4 %) and dextran (36 ± 15 %) was obtained 
in the presence of PP-50. No significant difference was observed for lacCer in the presence 
of PP-50. 
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Figure 2: Flow cytometry analysis of endocytosis tracers’ uptake on SAOS-2 in the presence 
or absence of PP-50. Cells were incubated with transferrin-488, lacCer-BODIPY or dextran-FITC 
(green fluorescence) in the presence or absence of 250 µg/ml PP-50/AF647 for 2 hrs. Fluorescence 
was obtained using a FACScan flow cytometer. Data are representative of a minimum of 3 separate 
experiments. Data were normalised to PP-50 (-) from each tracer. *P<0.05, **P<0.01. NS represents 
no significant difference.  
 
3.4. Metabolic activity analysis 
 
To analyse different endocytosis inhibitors involved in PP-50 mediated transport, the effect 
on metabolic activity of cells incubated with these molecules was previously investigated 
using the MTS assay (Fig. 3). The cytotoxicity was examined as a function of the inhibitors 
concentration within a 2 hour period. As seen in Fig. 3, nystatin and sucrose concentrations 
were not cytotoxic and were well tolerated by the cells. Mβcd and rottlerin showed a 
significant decrease in metabolic activity at concentrations higher than 10 mM and 5 mM, 
respectively. Concentrations of 5 mM mβcd, 2.5 µM rottlerin, 250 µg/ml nystatin, and 300 
mM sucrose were chosen to minimize their cytotoxic effects.  
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Figure 3: Metabolic activity of SAOS-2 cells after incubation for 2 hrs with different 
endocytosis inhibitors. A) Mβcd. B) Rottlerin. C) Nystatin. D) Sucrose. Data was normalised to cells 
incubated in the absence of the inhibitor. Data were derived from three replicates. Error bars 
represent standard error. Data were normalised to untreated cells. * P<0.05, ** P<0.01, *** P<0.001.  
 
3.5. PP-50 mediated calcein uptake after pre-treatment with endocytosis inhibitors 
 
To investigate the cell internalisation pathway of PP-50, endocytosis inhibition studies were 
conducted using flow cytometry. The inhibition of calcein uptake (a non-permeable dye) 
mediated by PP-50 was assessed by pre-treating cells with different endocytosis inhibitors 
(Fig. 4). As seen in Fig. 4, reduced levels of calcein uptake were seen when using CDE, 
CavME and MPC inhibitors. A significant decrease in calcein uptake compared to the control 
was found when cells were pre-incubated with mβcd (67 ± 5 %), nystatin (54 ± 14 %), 
sucrose (34 ± 4 %), and rottlerin (26 ± 10 %). Cells incubated at 4 °C also showed a 
significant decrease in calcein uptake (87 ± 4 %), with similar levels as those obtained with 
untreated cells. 
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Figure 4: Flow cytometry analysis of calcein uptake of SAOS-2 cells incubated with different 
endocytosis inhibitors in the presence of PP-50. Cells were first incubated for 1 hour with either 5 
mM mβcd, 250 µg/ml nystatin, 300 mM sucrose, or 2.5 µM rottlerin. Cells were then incubated with 2 
mM calcein and PP-50 (250 µg/ml) at 37 °C for 1 hour. A different treatment consisted of cells 
incubated with 2 mM calcein and PP-50 (250 µg/ml) at 4 °C. Error bars represent the standard error. 
Data are representative of a minimum of three separate experiments. CDE, CavME and MPC 
represent clathrin and caveolin-mediated endocytosis and macropinocytosis, respectively. Asterisks 
represent statistical significance compared to 37° C. *P<0.05, ***P<0.001, ****P<0.0001. NS 
represents no significant difference. 
 
3.6. Colocalisation of PP-50 with endolysosomal pathway markers 
 
The colocalisation of PP-50 with endolysosomal pathway markers was analysed by confocal 
microscopy in order to identify the fate of PP-50 when internalised. Cells were transduced 
with CellLight endosomes, late endosomes or lysosomes to produce GFP-labelled Rab5a, 
Rab7a, and Lamp-1, respectively. Cells were then incubated in the presence of PP-
50/AF647 for 2 and 24 hours (Fig. 5). Transient expression of endolysosomal proteins was 
obtained in osteosarcoma cells using CellLight reagents.  
 
After 2 hours of incubation, a small degree of colocalisation was observed between PP-
50/AF647 and the early endosome marker GFP-Rab5a. A higher degree of colocalisation 
was also observed with the late endosome marker Rab7a, although most of the polymer was 
able to escape the endolysosomal pathway before this incubation period (Fig. 5, upper 
panel). No PP-50/AF647 colocalisation was observed with the lysosome marker Lamp-1 
after 2 hrs. For a 24 hour incubation, no significant colocalisation was observed with either of 
the endolysosomal markers (Fig. 5, lower panel).  
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Figure 5: Confocal microscopy analysis of PP-50/AF647 colocalisation with markers for the 
endosomal pathway on SAOS-2. Cells were first transduced with CellLight reagents (early and late 
endosomes and lysosomes) and after 24 hrs cells were incubated for 2 and 24 hrs with PP50-AF647 
(250 µg/ml) (red fluorescence). Subsequently cells were stained with 5 µg/ml Hoechst H33342 (blue 
fluorescence) for 15 min. Data are representative of a minimum of three separate experiments. 
Arrows indicate colocalisation. 
 
4. Discussion 
 
In this study, the trafficking of PP-50 through the cell membrane was investigated in SAOS-2 
cells. Analysis of colocalisation with endocytosis tracers, inhibition of endosomal routes, as 
well as colocalisation with endolysosomal pathways markers showed that PP-50 is able to 
penetrate cell membranes, with the majority of the polymer escaping the endolysosomal 
pathway. 
 
To determine the internalisation pathway of PP-50, colocalisation of the polymer was 
investigated using molecules known to be taken up by specific endocytic routes: 1) 
transferrin, a CDE tracer; 2) lactosylceramide, a CIE tracer; and 3) dextran, a 
macropinocytosis tracer (Fig. 1) [21–23]. Usage of endocytic routes was quantitatively 
analysed using the Manders coefficient. The Manders coefficient compares the fluorescence 
of each pixel from two independent images and is almost independent of signal 
proportionality; it is primarily sensitive to co-occurrence, regardless of signal levels [25]. This 
number shows the fraction of transferrin, lacCer or dextran colocalised with the polymer, and 
varies from 0 for non-overlapping images to 1 for complete colocalisation [24,25]. The 
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coefficient was close to 0.5 for both transferrin and lacCer, and 0.336 ± 0.078 for dextran, 
suggesting that PP-50 is partially transported by CDE and CIE, and may also be trafficked 
by macropinocytosis to a lesser extent [26]. Both confocal visualisation and quantitative 
analysis of the colocalisation were in agreement, strongly indicating the involvement of cell 
receptor-based endocytosis for cellular uptake of PP-50. 
  
To investigate whether PP-50 directly induced additional transport of endocytosis tracers, 
transferrin, lacCer, and dextran were incubated in the presence and absence of the polymer 
and their uptake was assessed by flow cytometry (Fig. 2). The largest significant difference 
in uptake when incubated with the polymer was obtained for dextran, as PP-50 increased its 
uptake by over 35 %. This increase in dextran transport, a polysaccharide known to undergo 
MPC, could be partially attributed to a change in the fluidity of the cell membrane. Membrane 
fluidity refers to the viscosity of the lipid bilayer or the level of lipid membrane packaging [27]. 
Changes in plasma membrane fluidity or its electrostatic dipole potential have been shown to 
increase dextran transport in previous studies [28]. Therefore, PP-50 may not only be 
partially using this route but also inducing the fluidity of the cell membrane.  
 
To internalise molecules, CDE relies in clathrin-coated pits located in the cell membrane 
whereas CavME uses caveolin-formed vesicles, a type of lipid rafts composed of cholesterol, 
phospholipids or glycophospholipids [20,29–31]. On the other hand, macropinocytosis relies 
on actin to ingest large amounts of extracellular fluid [23]. The study of these pathways is 
normally investigated by selectively inhibiting different routes using pharmaceutical 
molecules [11,32,33]. In this work, CDE was inhibited using an hypertonic sucrose solution 
able to disperse clathrin lattices on the plasma membrane [34]. An inhibition of over 30 % 
was obtained, suggesting a participation of CDE in the trafficking of PP-50. Next, CavME 
inhibition was assessed using mβcd, a cyclic oligomer of glucopyranoside that acts as a 
cholesterol-depleting agent, and nystatin, a polyene antibiotic able to change properties of 
cholesterol-rich membrane domains [29,33,35]. Both mβcd and nystatin inhibited over 50 % 
of calcein uptake when compared to the control, indicating that CavME is partially involved in 
the transport of PP-50. Although inhibition of this route was accomplished, PP-50 may be 
using other caveolin or clathrin-independent mechanisms that also depend on lipid-rich 
areas of the membrane. These mechanisms have been found for different molecules such 
as cholera toxin B, but a distinction with CavME cannot be made at this point [36,37]. 
Macropinocytosis inhibition was investigated using rottlerin, a polycyclic aromatic compound, 
involved in the cytoskeletal reorganisation [38,39]. A 26 % inhibition of MPC was observed, 
indicating again the use of this pathway in a smaller degree compared to other routes. It is 
worth mentioning that the study of endocytosis pathways is still an evolving field that is not 
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fully understood. Although CDE is the most studied and frequently used for the cellular entry 
of internalised molecules, alternative mechanisms such as CIE are equally important 
[6,22,31]. 
 
Although CDE, CavME, and macropinocytosis were inhibited partially, none of the 
pharmaceutical endocytic inhibitors was able to fully inhibit PP-50 mediated calcein uptake. 
Other compounds were also used to inhibit endocytosis, such as genistein and 
chlorpromazine, but no significant difference in calcein uptake was found (data not shown) 
[40,41]. These results indicate that PP-50 is internalised through multiple endocytic 
pathways within a specific cell type, as commonly seen with most cell-penetrating peptides 
that rely on a combination of mechanisms rather than a single one [40,42]. In addition, this 
process appears to be temperature-dependent as seen by the inhibition of calcein uptake at 
4 °C, suggesting an active mechanism of internalisation [35]. 
 
In order to further characterise the intracellular fate of PP-50, cells were transduced with 
endosomes and lysosomes markers. Time points of 2 and 24 hours were chosen to ensure 
the visualisation of PP-50’s escape from the endolysosomal route, as previous studies have 
shown that endocytosis is a fast process [13]. Representative images of the colocalisation 
from the centre plane of the cells were obtained by confocal microscopy. After 2 hours of 
incubation with PP-50, confocal images suggest that most of the polymer has already 
escaped the lysosomal route, as evidence by the red and green staining rather than yellow. 
It was also observed that the polymer accumulated in the perinuclear region of cells. As PP-
50 mimics viral peptides that are able to penetrate cell, this is in agreement with the fate of 
DNA viruses that localise in this region to deposit their genomic DNA in the host nucleus 
[43–45]. After 24 hours of incubation with PP-50, little, if any of the polymer colocalised with 
these markers. Thus, PP-50 is likely to traffic through endosomes and lysosomes prior to the 
incubation time used in this experiment.  
 
The issue of biomolecular drug delivery into the cytoplasm is particularly important in order 
to reach eventual intracellular molecular targets and compartments. The choice of PP-50 as 
a drug delivery system has shown that amphipathic pH-responsive biopolymers are able to 
escape from lysosomes, an environment for proteolysis and degradation, by the disruption of 
endolysosomal membranes [7]. This is a key characteristic for the delivery of therapeutic 
molecules across the cell membrane. 
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Together, these findings suggest that PP-50 was able to escape from lysosomes, an 
environment for proteolysis and degradation, by the disruption of endolysosomal membranes 
[7]. This is a key characteristic for the delivery of therapeutic molecules across the cell 
membrane. 
 
5. Conclusions 
 
In this study, the cellular trafficking of an amphipathic pH-responsive biopolymer was 
studied. PP-50 colocalisation with different endocytosis tracers as well as quantitative image 
analysis showed that polymer cell internalisation relies mainly on clathrin and caveolin-
mediated endocytosis and to a lesser extent on macropinocytosis. PP-50-mediated uptake 
of calcein decreased when using CDE, CIE, and MPC inhibitors, also suggesting that the 
polymer relies on a combination of mechanisms rather than a single one for cell 
internalisation. Endosome and lysosome marker colocalisation with PP-50 showed that the 
polymer is able to escape the endolysosomal route in less than 2 hours. Further work is 
needed to determine the trafficking of PP-50 in different cell systems, such as suspension 
cells or in vivo models. This study provides an important step toward the use of amphipathic 
biopolymers for cryopreservation and biomedical applications. 
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 Highlights  
- Endocytosis mechanisms of an amphipathic biopolymer, PP-50, were evaluated in 
osteosarcoma cells  
- Colocalisation of PP-50 with different endolysosomal route markers was analysed  
- PP-50 relies on a combination of mechanisms rather than a single one for cell 
internalisation  
- PP-50 was shown to escape the endolysosomal compartment before maturation  
